MedTrace Logo

What After the First Propess

NCT02956785 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2022-11-14

No results posted yet for this study

Summary

The aim of this study is to compare three different regimens for continuation of induction of labor after no spontaneous or artificial rupture of membranes could be achieved after first 24 hours post-insertion of Dinoprostone

Conditions

  • Induction of Labor

Interventions

DRUG

10 mg Dinoprostone; CTS, UK

DRUG

3 mg Dinoprostone vaginal tablet; Pfizer, UK

DRUG

Aquacryl hydrogel rod; HPSRx Enterprises, USA

Sponsors & Collaborators

  • Medicem International

    collaborator UNKNOWN

  • Walsall Healthcare NHS Trust

    collaborator OTHER

  • South Warwickshire NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Amr H Farag, Consultant · Walsall Healthcare NHS Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2022-11-30
Completion
2022-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02956785 on ClinicalTrials.gov